Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma
This study has been completed.
Information provided by:
First received: March 6, 2007
Last updated: August 3, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2009|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Bruce JY, Eickhoff J, Pili R, Logan T and Carducci M, et al. A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Investigational New Drugs Online First™, 21 December 2010.